Literature DB >> 9712018

Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.

Y van de Wal1, Y Kooy, P van Veelen, S Peña, L Mearin, G Papadopoulos, F Koning.   

Abstract

Celiac disease (CD) is caused by gluten ingestion in susceptible individuals. Tissue transglutaminase (tTG)-specific Abs are characteristic of CD, and increased tTG activity has been observed in the jejunal biopsies of patients. Here we demonstrate that tTG selectively deamidates gluten peptides, which results in strongly enhanced T cell-stimulatory activity. To our knowledge, this is the first example of an enzymatic modification of a food protein that affects T cell recognition. Moreover, these modifications may lead to the amplification of gluten-specific T cell responses in the gut and consequently may be important for the development of CD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712018

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  147 in total

1.  Getting to grips with gluten.

Authors:  S N McAdam; L M Sollid
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  B cell epitopes of gliadin.

Authors:  A A Osman; T Günnel; A Dietl; H H Uhlig; M Amin; B Fleckenstein; T Richter; T Mothes
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 4.  A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics.

Authors:  Orit Rozenberg; Aaron Lerner; Avi Pacht; Maya Grinberg; Dina Reginashvili; Clara Henig; Mira Barak
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 5.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 6.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

7.  Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies.

Authors:  Maria Fiorella Mazzeo; Beatrice De Giulio; Stefania Senger; Mauro Rossi; Antonio Malorni; Rosa Anna Siciliano
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

Review 8.  Celiac disease.

Authors:  Debbie Williamson; Michael N Marsh
Journal:  Mol Biotechnol       Date:  2002-11       Impact factor: 2.695

9.  T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease.

Authors:  Jan Petersen; Veronica Montserrat; Jorge R Mujico; Khai Lee Loh; Dennis X Beringer; Menno van Lummel; Allan Thompson; M Luisa Mearin; Joachim Schweizer; Yvonne Kooy-Winkelaar; Jeroen van Bergen; Jan W Drijfhout; Wan-Ting Kan; Nicole L La Gruta; Robert P Anderson; Hugh H Reid; Frits Koning; Jamie Rossjohn
Journal:  Nat Struct Mol Biol       Date:  2014-04-28       Impact factor: 15.369

10.  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.

Authors:  Thomas R DiRaimondo; Nicholas M Plugis; Xi Jin; Chaitan Khosla
Journal:  J Med Chem       Date:  2013-01-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.